GPRC5D and Miyoshi myopathy: G protein-coupled receptor family C group 5 member D (GPRC5D) exhibits high selective expression on MM cell surfaces, and it remains unaffected by various anti-tumor therapies, such as IMiDs, PI, and CD38 Mabs [73].